Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis-Reference-Cited by-同舟云学术

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

Published:2020-08-28 Issue:8 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Murray Alistair¹,Nguyen Tran M²,Parker Claire E²,Feagan Brian G²³⁴,MacDonald John K³

Affiliation:

1. Schulich School of Medicine & Dentistry; University of Western Ontario; London Canada

2. Robarts Clinical Trials; London Canada

3. Department of Medicine; University of Western Ontario; London Canada

4. Department of Epidemiology and Biostatistics; University of Western Ontario; London Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference189 articles.

1. 5-aminosalicylic acid (5-ASA) versus salazopirin (SASP) in the oral treatment of active ulcerative colitis (UC) and in remission;Andreoli;Clinical Controversies in Inflammatory Bowel Disease,1987

2. Coated oral 50 aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis;Ardizzone;Journal of Clinical Gastroenterology,1995

3. Comparison of mesalazine with sulphasalazine in prophylactic treatment of ulcerative colitis;Bianchi Porro;Gut,1989

4. Is maintenance therapy always necessary for patients with ulcerative colitis?;Ardizzone;Alimentary Pharmacology and Therapeutics,1999

5. Randomised comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis;Courtney;Lancet,1992

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perception of fecal microbiota transplantation in patients with ulcerative colitis in Korea: a KASID multicenter study;The Korean Journal of Internal Medicine;2024-09-01

2. Common Mistakes in Managing Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-14

3. Practical management of mild-to-moderate ulcerative colitis: an international expert consensus;Expert Review of Gastroenterology & Hepatology;2024-08-02

4. Efficacy and safety of Xileisan combined with mesalazine for ulcerative colitis: A meta-analysis and trial sequential analysis;World Journal of Clinical Cases;2024-07-26

5. The continuing value of mesalazine as first-line therapy for patients with moderately active ulcerative colitis;Frontiers in Gastroenterology;2024-06-03